Ticker League

Alto Neuroscience (ANRO) Profit Bridge

See what drove Alto Neuroscience's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

Analysis
Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

TTM

Revenue YoY

Operating Income YoY

+178.54%

Net Income YoY

-17.60%

Net Margin Δ

Net income bridge for Alto Neuroscience (ANRO) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: -$11.1M-17.60%

Profit bridge breakdown for Alto Neuroscience (ANRO) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income-$63.2M
  • Revenue$0.00
  • Cost of Revenue-$114K
  • Operating Expenses$125M
  • Other Income / Expense-$136M
  • Income Tax$0.00
  • Net Loss-$74.3M
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation